MEDICAL MANAGEMENT OF METASTATIC RENAL CELL CARCINOMA, RETROSPECTIVE ANALYSIS OF REAL WORLD DATA SETTINGS

被引:0
|
作者
Kovacs, E. [1 ]
Nagy, B. [2 ]
Bidlo, J. [3 ]
机构
[1] Healthware Consulting Ltd, Budapest, Hungary
[2] Healthware Ltd, Budapest, Hungary
[3] Natl Hlth Insurance Fund Adm, Budapest, Hungary
关键词
D O I
10.1016/j.jval.2012.08.1212
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A412 / A412
页数:1
相关论文
共 50 条
  • [31] Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Gan, Chun Loo
    Dudani, Shaan
    Wells, J. Connor
    Donskov, Frede
    Pal, Sumanta K.
    Dizman, Nazli
    Rathi, Nityam
    Beuselinck, Benoit
    Yan, Flora
    Lalani, Aly-Khan A.
    Hansen, Aaron
    Szabados, Bernadett
    de Velasco, Guillermo
    Tran, Ben
    Lee, Jae Lyun
    Vaishampayan, Ulka N.
    Bjarnason, Georg A.
    Subasri, Mathushan
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    CANCER MEDICINE, 2021, 10 (04): : 1212 - 1221
  • [32] Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data
    Ishihara, Hiroki
    Takagi, Toshio
    Kondo, Tsunenori
    Fukuda, Hironori
    Tachibana, Hidekazu
    Yoshida, Kazuhiko
    Iizuka, Junpei
    Kobayashi, Hirohito
    Okumi, Masayoshi
    Ishida, Hideki
    Tanabe, Kazunari
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (05) : 793 - 801
  • [33] What is the role of real-world data in metastatic renal cell cancer?
    Ince, Will
    Fife, Kate
    FUTURE ONCOLOGY, 2021, 17 (30) : 3905 - 3909
  • [34] Real world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Stukalin, Igor
    Wells, J. Connor
    Graham, Jeffrey
    Yuasa, Takeshi
    Beuselinck, Benoit
    Kollmannsberger, Christian K.
    Ernst, D. Scott
    Agarwal, Neeraj
    Le, Tri
    Donskov, Frede
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Srinivas, Sandy
    Wood, Lori
    Alva, Ajjai Shivaram
    Kanesvaran, Ravindran
    Fu, Simon Yuen Fai
    Davis, Ian D.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [35] Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Stukalin, I
    Wells, J. C.
    Graham, J.
    Yuasa, T.
    Beuselinck, B.
    Kollmansberger, C.
    Ernst, D. S.
    Agarwal, N.
    Le, T.
    Donskov, F.
    Hansen, A. R.
    Bjarnason, G. A.
    Srinivas, S.
    Wood, L. A.
    Alva, A. S.
    Kanesvaran, R.
    Fu, S. Y. F.
    Davis, I. D.
    Choueiri, T. K.
    Heng, D. Y. C.
    CURRENT ONCOLOGY, 2019, 26 (02) : E175 - E179
  • [36] Real-world experience with cabozantinib in metastatic clear cell renal cell carcinoma (mccRCC).
    Lemke, Emily
    Shah, Amishi Yogesh
    Chandramohan, Anuradha
    Campbell, Matthew T.
    VanAlstine, Michael
    Jonasch, Eric
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [37] The medical management of metastatic renal cell carcinoma: integrating new guidelines and recommendations
    Bellmunt, Joaquim
    Guix, Marta
    BJU INTERNATIONAL, 2009, 103 (05) : 572 - 577
  • [38] Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data
    Maroun, Rana
    Mitrofan, Laura
    Benjamin, Laure
    Nachbaur, Gaelle
    Maunoury, Franck
    Le Jeunne, Philippe
    Durand-Zaleski, Isabelle
    BMC CANCER, 2018, 18
  • [39] Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data
    Rana Maroun
    Laura Mitrofan
    Laure Benjamin
    Gaelle Nachbaur
    Franck Maunoury
    Philippe Le Jeunne
    Isabelle Durand-Zaleski
    BMC Cancer, 18
  • [40] Cabozantinib in metastatic renal cell carcinoma (mRCC): Real world experience from the UK
    de Liano, Alfonso Gomez
    Venugopal, Balaji
    Fife, Kate
    Khasti, Luma
    Symeonides, Stefan N.
    Pettinger, Claire
    Powles, Thomas
    Rudman, Sarah Maria
    Vasudev, Naveen
    Boleti, Ekaterini
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)